| Authors: |
Han A; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Yermalovich A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Najia MAT; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA, USA.; Stem Cell Program, Boston Children's Hospital, Boston, MA, USA., Pearson DS; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Fujiwara Y; Dana-Farber/Boston Children's Hospital Cancer and Blood Disorder Center, Department of Pediatrics, Harvard Medical School, Boston, MA, USA.; Howard Hughes Medical Institute, Harvard Medical School, Boston, MA, USA., Bolgov M; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA., Kubaczka C; Stem Cell Program, Boston Children's Hospital, Boston, MA, USA., North TE; Stem Cell Program, Boston Children's Hospital, Boston, MA, USA.; Developmental and Regenerative Biology Program, Harvard Medical School, Boston, MA, USA., Lundin V; Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, Huddinge, Sweden., Orkin S; Dana-Farber/Boston Children's Hospital Cancer and Blood Disorder Center, Department of Pediatrics, Harvard Medical School, Boston, MA, USA.; Howard Hughes Medical Institute, Harvard Medical School, Boston, MA, USA., Daley GQ; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Stem Cell Program, Boston Children's Hospital, Boston, MA, USA. |
